Who is missed in a community-based survey: Assessment and implications of biases due to incomplete sampling frame in a community-based serosurvey, Choma and Ndola Districts, Zambia, 2022.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2024
Historique:
received: 10 09 2023
accepted: 10 03 2024
medline: 29 4 2024
pubmed: 29 4 2024
entrez: 29 4 2024
Statut: epublish

Résumé

Community-based serological studies are increasingly relied upon to measure disease burden, identify population immunity gaps, and guide control and elimination strategies; however, there is little understanding of the potential for and impact of sampling biases on outcomes of interest. As part of efforts to quantify measles immunity gaps in Zambia, a community-based serological survey using stratified multi-stage cluster sampling approach was conducted in Ndola and Choma districts in May-June 2022, enrolling 1245 individuals. We carried out a follow-up study among individuals missed from the sampling frame of the serosurvey in July-August 2022, enrolling 672 individuals. We assessed the potential for and impact of biases in the community-based serosurvey by i) estimating differences in characteristics of households and individuals included and excluded (77% vs 23% of households) from the sampling frame of the serosurvey and ii) evaluating the magnitude these differences make on healthcare-seeking behavior, vaccination coverage, and measles seroprevalence. We found that missed households were 20% smaller and 25% less likely to have children. Missed individuals resided in less wealthy households, had different distributions of sex and occupation, and were more likely to seek care at health facilities. Despite these differences, simulating a survey in which missed households were included in the sampling frame resulted in less than a 5% estimated bias in these outcomes. Although community-based studies are upheld as the gold standard study design in assessing immunity gaps and underlying community health characteristics, these findings underscore the fact that sampling biases can impact the results of even well-conducted community-based surveys. Results from these studies should be interpreted in the context of the study methodology and challenges faced during implementation, which include shortcomings in establishing accurate and up-to-date sampling frames. Failure to account for these shortcomings may result in biased estimates and detrimental effects on decision-making.

Identifiants

pubmed: 38683820
doi: 10.1371/journal.pgph.0003072
pii: PGPH-D-23-01791
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0003072

Informations de copyright

Copyright: © 2024 Kostandova et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Natalya Kostandova (N)

Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Simon Mutembo (S)

Department of International Health, International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Christine Prosperi (C)

Department of International Health, International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Francis Dien Mwansa (FD)

Department of Immunizations, Ministry of Health, Government of the Republic of Zambia, Lusaka, Zambia.

Chola Nakazwe (C)

Information, Research and Dissemination, Zambia Statistics Agency, Lusaka, Zambia.

Harriet Namukoko (H)

Population and Social Statistics, Zambia Statistics Agency, Lusaka, Zambia.

Bertha Nachinga (B)

Information, Research and Dissemination, Zambia Statistics Agency, Lusaka, Zambia.

Gershom Chongwe (G)

Tropical Diseases Research Centre, Ndola, Zambia.

Innocent Chilumba (I)

Biomedial Sciences Department, Tropical Diseases Research Centre, Ndola, Zambia.

Kalumbu H Matakala (KH)

Clinical Research Department, Macha Research Trust, Macha, Zambia.

Gloria Musukwa (G)

Macha Research Trust, Macha, Zambia.

Mutinta Hamahuwa (M)

Clinical Research Laboratory Department, Macha Research Trust, Macha, Zambia.

Webster Mufwambi (W)

Administration, Tropical Diseases Research Centre, Ndola, Zambia.

Japhet Matoba (J)

Molecular Biology Department, Macha Research Trust, Macha, Zambia.

Kenny Situtu (K)

Tropical Diseases Research Centre, Ndola, Zambia.

Irene Mutale (I)

Tropical Diseases Research Centre, Ndola, Zambia.

Alex C Kong (AC)

Department of International Health, International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Edgar Simulundu (E)

Macha Research Trust, Macha, Zambia.

Phillimon Ndubani (P)

Macha Research Trust, Macha, Zambia.

Alvira Z Hasan (AZ)

Department of International Health, International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Shaun A Truelove (SA)

Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Department of International Health, International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Amy K Winter (AK)

Department of International Health, International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Department of Epidemiology and Biostatistics, University of Georgia, Athens, Georgia, United States of America.

Andrea C Carcelen (AC)

Department of International Health, International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Bryan Lau (B)

Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

William J Moss (WJ)

Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Department of International Health, International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Amy Wesolowski (A)

Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Classifications MeSH